Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)?: In vitro versus in vivo results and the relevance for the prevention and treatment of cancer

Biochemical Pharmacology

Volumn 63, Issue 3, 2002, Pages 343-347

  Raz, Amiram ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; COX 1; COX 2; Cyclooxygenase; PGE2; Prostanoids

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTANOID; SULINDAC; SULINDAC SULFIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CELL CYCLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME RELEASE; FATTY ACID SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; ION TRANSPORT; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL CULTURE; TUMOR GROWTH;

EID: 0036471967     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00857-7     Document Type: Note

References (35)

1. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
2. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis
3. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins
4. Sulindac sulfide inhibits the proliferation of colon cancer cells: Diminished expression of the proliferation markers PCNA and Ki-67
5. Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells
6. Sulindac sulfide induces several subpopulations of colon cancer cells, defined by PCNA/Ki-67 and DNA strand breaks
7. Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells
8. Effects of NSAIDs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
9. Exisulindac (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograph model by increasing apoptosis
10. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines
11. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
12. The mechanism of action of nonsteroidal anti-inflammatory drugs
13. 15-Lipoxygenase-1 mediates NSAID-induced apoptosis independently of cycloxygenase-2 in colon cancer cells
14. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis
15. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells
16. Malignant transformation and antineoplastic actions of NSAIDs on cyclooxygenase null embryo fibroblasts
17. Apoptosis primarily accounts for the growth inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest and p53 induction
18. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress activated protein kinase activation
19. Inhibition of NF-κB by sodium salicylate and aspirin
20. Salicylates inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration
21. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models
22. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors
23. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for transcriptional effects
24. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
25. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2)
26. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
27. Meloxican inhibits the growth of colorectal cancer cells
28. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
29. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction
30. R- and S-isomers of nonsteroidal anti-inflammatory drugs differentially regulate cytokine production
31. Min/+ (Min) mouse with R-flurbiprofen
32. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse
33. Pure enantiomers of 2-arylpropionic acids: Tools in pain research and improved drugs in rheumatology
34. The metabolic chiral inversion of 2-arylpropionic acid - A novel route with pharmacological consequences
35. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drug. IV. Ketoprofen disposition